Edwards Lifesciences Corporation ( EW) - Key Metrics
EW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $2.35 | $0.65 | -$0.22 | -$0.30 |
| 2024Q3 | $2.27 | $5.14 | $0.59 | $0.54 |
| 2024Q2 | $2.30 | $0.61 | $0.62 | $0.48 |
| 2024Q1 | $2.66 | $0.58 | -$0.09 | -$0.23 |
| 2023Q4 | $2.53 | $0.61 | $0.23 | $0.06 |
EW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | 28.31 |
| 2024Q3 | ? | 3.21 |
| 2024Q2 | ? | 37.09 |
| 2024Q1 | ? | 40.28 |
| 2023Q4 | ? | 31.19 |
EW
Price: $73.83
52 week price:
Earnings Per Share: 2.42 USD
P/E Ratio: 32.17
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 2.2 million
Ebitda: 328.1 millionMarket Capitalization: 45.7 billion